Inside the research
UnitedHealth Group Incorporated
UNH Research profile · latest available data
Price overview
$376.59
▲ +1.58 (+0.4%)
| 52w hi | $433.68 |
|---|---|
| 52w lo | $255.97 |
| Vol | 4.08M |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.14
| Short | -0.06 |
|---|---|
| Medium | +0.25 |
| Long | +0.34 |
computed 2026-09-27
Key fundamentals
UnitedHealth Group Incorporated
Healthcare · Healthcare Plans
| Market cap | $338.03B |
|---|---|
| Enterprise value | $387.39B |
| Trailing P/E | 24.22x |
| Forward P/E | 16.66x |
| EV / EBITDA | 14.52x |
| P / S (ttm) | 0.75x |
| Profit margin | 3.1% |
| Return on equity | 14.2% |
| Revenue growth | +0.4% |
| Earnings growth | +61.5% |
| Debt / equity | 69.21 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.27 | |
| Sector | +0.08 | |
| Technical | -0.01 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
Risk Metrics
| Beta vs SPX | 0.33 |
|---|---|
| Corr SPX | 0.13 |
| Annual vol | 42.2% |
| Annual ret | -11.8% |
| Sharpe | -0.28 |
| Max DD | -62.0% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $387.27 |
|---|---|
| High / Low | $444.00 / $287.00 |
| Median | $400.00 |
| Analysts | 26 |
| Strong Buy | 7 | |
|---|---|---|
| Buy | 16 | |
| Hold | 4 | |
| Sell | 1 | |
| Strong Sell | 0 |
Recent rating actions
| 2026-04-28 | JP Morgan | → Overweight |
| 2026-04-23 | TD Cowen | → Hold |
| 2026-04-22 | Wells Fargo | → Overweight |
| 2026-04-22 | Truist Securities | → Buy |
| 2026-04-22 | RBC Capital | → Outperform |
| 2026-04-22 | Oppenheimer | → Outperform |
Officers & Board
| Director | Charlie Baker since 2023 |
|---|---|
| Director | Kristen L. Gil since 2022 |
| Director | Paul Garcia since 2021 |
| Director | Andrew Witty since 2021 |
| CEO | Andrew Witty since 2021 |
| Director | John H. Noseworthy since 2019 |
| Director | F. William McNabb III since 2018 |
| Director | Valerie Montgomery Rice since 2017 |
| Director | Timothy P. Flynn since 2017 |
| Director | Michele J. Hooper since 2007 |
| Director | Stephen J. Hemsley since 2000 |
| Director | Q131385766 current |
| Manager | Stephen J. Hemsley current |
| Founder | Richard T. Burke current |
| Director | Gail Wilensky 1993–2002 |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-16 | Earnings Release, Exhibits | read |
| 2026-06-05 | Shareholder Vote | read |
| 2026-05-11 | Reg FD Disclosure | read |
| 2026-04-21 | Earnings Release, Exhibits | read |
| 2026-03-09 | Reg FD Disclosure | read |
| 2026-03-02 | Officer / Director Change | read |
| 2026-02-25 | Officer / Director Change | read |
| 2026-01-27 | Earnings Release, Exhibits | read |
| 2026-01-12 | Reg FD Disclosure | read |
| 2025-11-21 | Officer / Director Change | read |
| 2025-11-13 | Bylaws Amendment | read |
| 2025-11-07 | Reg FD Disclosure | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-11 | Stankiewicz Dennis Andrew | Chief Accounting Officer | Withheld for tax | 233 | $93.87K |
| 2026-08-05 | Conway Patrick Hugh | Chief Executive Officer, | Sell | 500 | $205.00K |
| 2026-07-01 | GARCIA PAUL R | Grant | 132 | — | |
| 2026-07-01 | MONTGOMERY RICE VALERIE MD | Grant | 220 | — | |
| 2026-07-01 | Gottlieb Scott | Grant | 210 | — | |
| 2026-07-01 | Gil Kristen | Grant | 206 | — | |
| 2026-07-01 | MCNABB FREDERICK WILLIAM III | Grant | 250 | — | |
| 2026-07-01 | GARCIA PAUL R | Grant | 88 | — | |
| 2026-07-01 | Noseworthy John H | Grant | 206 | — | |
| 2026-07-01 | FLYNN TIMOTHY PATRICK | Grant | 225 | — |
Flow & Concentration
| Insider 180d net | -$489.00K |
|---|---|
| Insider buys / sells | 0 / 2 |
| Insider bias | Neutral |
| 13F holders | 0 |
| Top-5 share | 0.0% |
| HHI | 0 (—) |
Dividends
| Yield (TTM) | 1.17% |
|---|---|
| $ / share (TTM) | $4.42 |
| 5y CAGR | +12.6% |
Annual dividend per share
| 2021 | $5.60 |
|---|---|
| 2022 | $6.40 |
| 2023 | $7.29 |
| 2024 | $8.18 |
| 2025 | $8.73 |
| 2026 | $2.21 |
Federal Contracts
| Amount | Agency | Description |
|---|---|---|
| $13.15B | Department of Defense | T3 MANAGED CARE SUPPORT CONTRACT FOR WEST REGION |
| $11.33M | Department of the Treasury | IGF::OT::IGF. VISION INSURANCE ADMINISTRATIVE SERVICES |
SEC Filings
The Long Run
FY 2009–2025 · 17 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $447.57B | +11.3% | |
| Operating income | $18.96B | +7.1% | |
| Net income | $22.38B | +10.3% | |
| Cash from ops | $19.70B | +8.1% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $375.95 | $379.17 | $371.17 | $376.59 | 4.08M |
| Sep 24 | $371.92 | $375.28 | $368.50 | $375.01 | 4.65M |
| Sep 23 | $370.89 | $372.61 | $366.00 | $371.29 | 3.86M |
| Sep 22 | $381.39 | $381.39 | $372.41 | $372.95 | 4.50M |
| Sep 21 | $377.87 | $378.95 | $373.82 | $377.56 | 5.71M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →